Tau mAb
Alzheimer's Disease + rare disease
Pre-clinicalActive
Key Facts
About Manifold Bio
Manifold Bio is a private, preclinical-stage biotech based in Cambridge, MA, founded in 2019. The company has developed a unique platform that integrates AI-guided protein design with direct, high-throughput in vivo testing to engineer biologics with precise tissue-targeting properties. Its initial pipeline focuses on CNS-targeted therapies for Alzheimer's and Parkinson's diseases, with a broader vision to build a 'virtual organism' predictive model. The company is backed by notable investors and has entered a strategic collaboration with Roche.
View full company profileTherapeutic Areas
Other Alzheimer's Disease + rare disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Tau Oligo | Manifold Bio | Pre-clinical |
| aSyn Oligo | Manifold Bio | Pre-clinical |